Overview
Acid phosphatase is a hydrolytic enzyme that removes phosphate groups from organic compounds under acidic conditions, with optimum activity at pH 4 to 6. It is widely distributed in the body, with the prostate being the major source, along with liver, spleen, kidney, bone marrow, erythrocytes, platelets, and lysosomes. Total acid phosphatase measurement reflects the combined activity of its isoenzymes and has diagnostic relevance in prostate disorders, bone diseases, and lysosomal storage disorders. Although its role has declined with the advent of more specific markers, it remains useful in selected clinical situations.
Symptoms
Abnormal acid phosphatase levels do not produce symptoms by themselves, but they are associated with underlying conditions. Patients with prostate cancer or benign prostatic hyperplasia may present with urinary symptoms such as hesitancy, poor stream, or retention. Bone-related disorders may present with bone pain, deformities, or fractures. Hematological and lysosomal storage disorders may cause fatigue, anemia, organomegaly, or systemic symptoms depending on disease severity.
Causes
Increased total acid phosphatase levels are commonly seen in prostate cancer, especially with metastatic disease, benign prostatic hyperplasia, and following prostate manipulation. Bone disorders such as Paget’s disease, osteoclastoma, osteoclastic tumors, osteopetrosis, and hyperparathyroidism can elevate levels due to increased bone resorption. Hematological conditions like hairy cell leukemia and hemolytic anemia, as well as lysosomal storage disorders such as Gaucher’s disease, also contribute to raised enzyme activity. Transient elevations may occur after prostate massage or infarction.
Risk Factors
Risk factors for elevated acid phosphatase include advancing age, male sex, prostate disease, bone disorders with increased osteoclastic activity, and inherited metabolic or lysosomal conditions. Patients with known malignancies, chronic bone disease, or hematological disorders are more likely to show abnormal levels. Improper sample handling, hemolysis, or delayed serum separation can falsely affect results.
Prevention
While the elevation of acid phosphatase itself cannot be prevented, early detection and management of underlying conditions reduce complications. Appropriate screening and monitoring of prostate disease, timely evaluation of bone pain or deformities, and early diagnosis of metabolic and hematological disorders are important. Proper blood sample collection, rapid serum separation, and correct storage help ensure reliable results. Correlation with clinical findings and other markers such as PSA improves diagnostic accuracy and patient management.
